Depression and type 2 diabetes mellitus: The multiethnic study of atherosclerosis

被引:62
|
作者
Golden, Sherita Hill [1 ]
Lee, Hochang Benjamin
Schreiner, Pamela J.
Roux, Ana Diez
Fitzpatrick, Annette L.
Szklo, Moyses
Lyketsos, Constantine
机构
[1] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Dept Med, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD 21205 USA
[4] Univ Minnesota, Div Epidemiol, St Paul, MN 55108 USA
[5] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA
[6] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
来源
PSYCHOSOMATIC MEDICINE | 2007年 / 69卷 / 06期
关键词
diabetes mellitus; impaired fasting glucose; depression; epidemiology; insulin resistance;
D O I
10.1097/PSY.0b013e3180f61c5c
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To assess the cross-sectional association between depression and glucose tolerance status. Methods: We conducted a study of 6754 White, Black, Hispanic, and Chinese men and women aged 45 to 84 years in the Multiethnic Study of Atherosclerosis (MESA). Depression was defined as Center for Epidemiologic Studies Depression scale score of >= 16 and/or antidepressant use. Glucose tolerance status was defined as normal, impaired fasting glucose (IFG) or Type 2 diabetes mellitus (untreated and treated). Results: In the minimally adjusted model, although depression was not associated with a greater odds of IFG (odds ratio (OR) = 1.01; 95% confidence interval (CI): 0.87-1.18) or untreated diabetes (OR = 1.03; 95% CI: 0.74-1.45), it was associated with a greater odds of treated diabetes (OR = 1.57; 95% CI: 1.27-1.96). This persisted following adjustment for body mass index (OR 1.52; 95% CI: 1.22-1.90), metabolic (OR = 1.54; 95% CI: 1.23-1.93), and inflammatory (OR = 1.53; 95% CI: 1.21-1.92) factors, daily caloric intake and smoking (OR = 1.48; 95% CI: 1.16-1.88), and socioeconomic markers (OR = 1.47; 95% CI: 1.17-1.85). Among individuals with treated diabetes, median depression scores were higher in those with microalbuminuria compared with those without microalbuminuria (median = 7; interquartile range: 3-13 versus median = 6; interquartile range: 2-11; p = .046). Depression scores were not associated with homeostatic model assessment of insulin resistance among individuals without diabetes. Conclusions: In MESA, depression was significantly associated with treated diabetes. Further studies are needed to determine the temporality of this association.
引用
收藏
页码:529 / 536
页数:8
相关论文
共 50 条
  • [41] Study on risk factors of carotid atherosclerosis in type 2 diabetes mellitus and development of prediction model
    Chen, Xiaohuan
    Shi, Jiacheng
    Hu, Yulan
    Ma, Huanhuan
    Jiang, Zhonghua
    Lou, Bo
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2025, 45 (01) : 234 - 242
  • [42] Beta 2 Microglobulin and Subclinical Atherosclerosis in Normoalbuminuric Type 2 Diabetes Mellitus
    Jang, Eun-Hee
    Kim, Mee-Kyoung
    Baek, Ki-Hyun
    Song, Ki-Ho
    Cha, Bong-Yun
    Kwon, Hyuk-Sang
    DIABETES, 2013, 62 : A110 - A110
  • [43] Microvesicles - potential biomarkers for the interrelations atherosclerosis/type 2 diabetes mellitus
    Aurelian, Sorina Maria
    Cheta, Dan Mircea
    Onicescu, Doina
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2014, 55 (03): : 1035 - 1039
  • [44] Biochemical Markers of Subclinical Atherosclerosis in Patients with Type 2 Diabetes Mellitus
    Osorio Sosa, Caridad
    Napoles Acosta, Leonar Luis
    Valles Gamboa, Alfredo Salvador
    Caballero Laguna, Alberto
    FINLAY, 2022, 12 (02):
  • [45] Subclinical Carotid Atherosclerosis in Asymptomatic Subjects With Type 2 Diabetes Mellitus
    Rubinat, Esther
    Ramon Marsal, Josep
    Vidal, Teresa
    Cebrian, Cristina
    Falguera, Mireia
    Belen Vilanova, Ma.
    Betriu, Angels
    Fernandez, Elvira
    Franch, Josep
    Mauricio, Didac
    JOURNAL OF CARDIOVASCULAR NURSING, 2016, 31 (02) : E1 - E7
  • [46] Early atherosclerosis and dehydroepiandrosterone sulphate in patients with type 2 diabetes mellitus
    Vasiliadis, M.
    Papaioakim, M.
    Heliopoulos, I.
    Toromanidou, M.
    Nikelli, M.
    Gioka, T.
    Tsiligiris, A.
    Tavridou, A.
    Pagkalos, E.
    DIABETOLOGIA, 2009, 52 : S518 - S519
  • [47] Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment
    Semenkovich, Katherine
    Brown, Miriam E.
    Svrakic, Dragan M.
    Lustman, Patrick J.
    DRUGS, 2015, 75 (06) : 577 - 587
  • [48] Assessing Prevalence and Predictors of Depression in Type 2 Diabetes Mellitus
    Dastidar, Biswajit Ghosh
    Ghosal, Samit
    Gangopadhyay, Kalyan
    Ray, Subir
    Majumdar, Sujoy
    Mazumdar, Anirban
    Mukherjee, Jagat Jyoti
    Sinha, Binayak
    DIABETES, 2017, 66 : A217 - A217
  • [49] Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus
    Karaiskos, D.
    Tzavellas, E.
    Ilias, I.
    Liappas, I.
    Paparrigopoulos, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (03) : 257 - 260
  • [50] Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment
    Katherine Semenkovich
    Miriam E. Brown
    Dragan M. Svrakic
    Patrick J. Lustman
    Drugs, 2015, 75 : 577 - 587